ALK and lung cancer: In lung cancer, BRAF V600E typically occurs in never-smokers, with adenocarcinoma histology, and lacks other common driver mutations, resembling other oncogene-driven cancers such as EGFR or anaplastic lymphoma kinase (ALK)-mutated tumors [58].